DECIEM, the parent company of The Ordinary and NIOD, has officially inaugurated its state-of-the-art, 50,000-square-foot Research and Development facility in Toronto. The massive investment cements the city's status as a global hub for clinical skincare innovation and biotechnology.

This new facility allows our chemists and bioengineers to accelerate the discovery of novel, high-efficacy ingredients while maintaining our strict commitment to clinical integrity and functional honesty.

The Toronto hub features advanced formulation labs, microbiology testing suites, and sustainable packaging design studios. DECIEM plans to hire over 200 local scientists and researchers over the next two years, significantly boosting the Canadian beauty industry's technical talent pool.